Cannabis and Opioid Use Disorder

Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorShanna Babalonis, PhD

About this trial

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Eligibility criteria

Qualifiers

Current opioid use disorder

Disqualifiers

Current medical conditions that require medical management

Trial design

Treatments tested in this trial

  • Inhaled vaporized cannabis
  • Intransal opioid

Treatment groups

15 Participants
are divided into 2 treatment groups

Locations

1
Center on Drug and Alcohol Research40508, LexingtonKentucky, United States

Sponsors and collaborators

Shanna Babalonis, PhD

Lead sponsor

University of Kentucky

Sponsor institution

National Institute on Drug Abuse (NIDA)

Collaborator